Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for PAX5
Z-value: 7.43
Motif logo
Transcription factors associated with PAX5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PAX5
|
ENSG00000196092.14 | PAX5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PAX5 | hg38_v1_chr9_-_37025733_37025753 | 0.56 | 2.5e-19 | Click! |
Activity profile of PAX5 motif
Sorted Z-values of PAX5 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of PAX5
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.5 | 16.6 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 5.5 | 16.5 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 4.4 | 13.3 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 4.3 | 30.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 4.3 | 13.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 4.3 | 17.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 4.2 | 16.8 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 4.0 | 12.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 3.9 | 11.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 3.8 | 23.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 3.7 | 25.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 3.7 | 11.1 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 3.7 | 21.9 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
| 3.5 | 10.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 3.5 | 14.0 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 3.4 | 10.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 3.3 | 6.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 3.3 | 10.0 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 3.3 | 9.9 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 3.3 | 13.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 3.3 | 19.7 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 3.2 | 9.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 3.2 | 3.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 3.2 | 15.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 3.2 | 447.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 3.2 | 15.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 3.2 | 9.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 3.1 | 9.4 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 3.1 | 3.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 3.0 | 12.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 3.0 | 3.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 2.9 | 11.5 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 2.9 | 8.6 | GO:2000777 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.8 | 8.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 2.8 | 8.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 2.7 | 2.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) negative regulation of catecholamine secretion(GO:0033604) |
| 2.7 | 10.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 2.7 | 2.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 2.7 | 5.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 2.7 | 8.0 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.7 | 8.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 2.7 | 8.0 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 2.6 | 7.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 2.5 | 7.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 2.5 | 7.6 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 2.5 | 2.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 2.5 | 19.9 | GO:0015747 | urate transport(GO:0015747) |
| 2.5 | 9.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 2.4 | 9.8 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.4 | 31.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 2.4 | 7.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 2.4 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 2.4 | 7.2 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 2.3 | 18.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 2.3 | 16.1 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 2.3 | 2.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 2.2 | 15.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 2.2 | 17.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 2.2 | 8.8 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 2.2 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 2.1 | 14.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 2.1 | 76.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 2.1 | 2.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 2.1 | 6.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.1 | 6.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 2.1 | 8.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 2.1 | 6.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 2.0 | 6.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 2.0 | 6.1 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 2.0 | 18.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.0 | 8.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 2.0 | 6.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 2.0 | 9.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 2.0 | 2.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 2.0 | 5.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 1.9 | 9.7 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 1.9 | 7.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.9 | 1.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 1.9 | 3.8 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 1.9 | 5.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 1.9 | 5.6 | GO:1905237 | response to cyclosporin A(GO:1905237) |
| 1.8 | 9.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 1.8 | 5.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 1.8 | 12.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 1.8 | 5.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 1.8 | 12.5 | GO:0045007 | depurination(GO:0045007) |
| 1.8 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 1.8 | 5.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.8 | 7.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 1.7 | 5.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.7 | 12.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.7 | 6.9 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.7 | 3.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 1.7 | 15.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 1.7 | 1.7 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.7 | 8.3 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.7 | 3.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.6 | 8.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.6 | 6.5 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.6 | 4.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 1.6 | 4.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 1.6 | 9.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.6 | 6.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.6 | 4.7 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.6 | 4.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 1.6 | 4.7 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.6 | 14.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.6 | 7.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.6 | 7.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.6 | 4.7 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
| 1.5 | 6.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.5 | 4.6 | GO:0036292 | DNA rewinding(GO:0036292) |
| 1.5 | 12.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 1.5 | 3.0 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.5 | 4.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.5 | 15.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.5 | 3.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.5 | 4.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.5 | 1.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.5 | 42.7 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 1.5 | 5.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.5 | 4.4 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 1.5 | 4.4 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 1.4 | 21.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 1.4 | 4.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.4 | 10.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.4 | 7.1 | GO:0033504 | floor plate development(GO:0033504) |
| 1.4 | 8.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 1.4 | 2.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 1.4 | 11.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 1.4 | 9.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.4 | 8.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 1.4 | 4.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 1.4 | 12.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.4 | 4.1 | GO:0048241 | epinephrine transport(GO:0048241) |
| 1.4 | 2.8 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.4 | 4.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 1.4 | 11.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 1.4 | 4.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 1.4 | 23.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.4 | 2.7 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 1.4 | 2.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.4 | 6.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 1.4 | 5.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.3 | 20.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 1.3 | 4.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 1.3 | 4.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 1.3 | 1.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.3 | 4.0 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 1.3 | 14.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.3 | 3.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.3 | 2.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 1.3 | 5.2 | GO:0019086 | late viral transcription(GO:0019086) |
| 1.3 | 3.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 1.3 | 5.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.3 | 3.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.3 | 28.3 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 1.3 | 9.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 1.3 | 3.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.3 | 21.6 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.3 | 13.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.3 | 5.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 1.2 | 1.2 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 1.2 | 7.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 1.2 | 6.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.2 | 4.9 | GO:0070417 | cellular response to cold(GO:0070417) |
| 1.2 | 3.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.2 | 7.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 1.2 | 4.8 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.2 | 11.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 1.2 | 7.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 1.2 | 3.6 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 1.2 | 9.5 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 1.2 | 4.7 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 1.2 | 4.7 | GO:1903238 | regulation of leukocyte tethering or rolling(GO:1903236) positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 1.2 | 34.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 1.2 | 22.3 | GO:0001562 | response to protozoan(GO:0001562) |
| 1.2 | 8.2 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.2 | 5.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.2 | 5.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.2 | 3.5 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.2 | 5.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.2 | 2.3 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 1.2 | 3.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.2 | 6.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.1 | 4.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 1.1 | 26.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 1.1 | 3.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 1.1 | 2.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 1.1 | 2.3 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.1 | 3.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.1 | 2.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 1.1 | 3.4 | GO:0072716 | response to actinomycin D(GO:0072716) |
| 1.1 | 15.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 1.1 | 8.9 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.1 | 7.8 | GO:0051026 | chiasma assembly(GO:0051026) |
| 1.1 | 3.3 | GO:1903279 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 1.1 | 6.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 1.1 | 3.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.1 | 10.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 1.1 | 5.5 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 1.1 | 4.4 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.1 | 4.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 1.1 | 12.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.1 | 3.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.1 | 3.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 | 2.2 | GO:0060032 | notochord regression(GO:0060032) |
| 1.1 | 10.8 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 1.1 | 5.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.1 | 6.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.1 | 1.1 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) negative regulation of fibroblast growth factor production(GO:0090272) |
| 1.1 | 4.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 1.1 | 6.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.1 | 3.2 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.1 | 4.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.1 | 3.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 1.1 | 3.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.1 | 6.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.1 | 3.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 1.0 | 13.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 1.0 | 4.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 1.0 | 3.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.0 | 4.2 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 1.0 | 4.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 1.0 | 7.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 1.0 | 2.1 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.0 | 8.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 1.0 | 10.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.0 | 4.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.0 | 6.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 1.0 | 2.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 1.0 | 4.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 | 15.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.0 | 7.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 1.0 | 4.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.0 | 12.0 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 1.0 | 3.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 1.0 | 19.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.0 | 7.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.0 | 5.9 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 1.0 | 2.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.0 | 1.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 1.0 | 2.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.0 | 14.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 | 2.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 1.0 | 2.9 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 1.0 | 3.9 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 1.0 | 3.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 1.0 | 1.9 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.0 | 5.8 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 1.0 | 4.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.9 | 16.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.9 | 2.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.9 | 9.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 | 2.8 | GO:0071812 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.9 | 4.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.9 | 4.7 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
| 0.9 | 5.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.9 | 2.8 | GO:0072011 | diapedesis(GO:0050904) glomerular endothelium development(GO:0072011) |
| 0.9 | 2.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.9 | 15.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.9 | 4.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.9 | 3.7 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.9 | 8.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.9 | 1.8 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.9 | 2.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.9 | 6.4 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.9 | 8.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.9 | 3.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.9 | 7.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.9 | 1.8 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.9 | 6.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.9 | 3.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.9 | 4.5 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.9 | 6.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.9 | 11.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.9 | 2.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.9 | 2.7 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.9 | 7.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.9 | 15.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.9 | 5.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.9 | 1.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.9 | 6.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 2.6 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.9 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.9 | 6.9 | GO:0001554 | luteolysis(GO:0001554) |
| 0.9 | 6.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.9 | 1.7 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.9 | 1.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.9 | 2.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.9 | 3.4 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.9 | 2.6 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.9 | 18.7 | GO:0097503 | sialylation(GO:0097503) |
| 0.8 | 2.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.8 | 4.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.8 | 5.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.8 | 1.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.8 | 12.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.8 | 5.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.8 | 10.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.8 | 2.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 | 2.5 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.8 | 3.3 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.8 | 2.5 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.8 | 3.3 | GO:1904139 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.8 | 17.4 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.8 | 3.3 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.8 | 1.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.8 | 0.8 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.8 | 2.5 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.8 | 4.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.8 | 10.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.8 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.8 | 4.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.8 | 4.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.8 | 2.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.8 | 0.8 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) nucleobase catabolic process(GO:0046113) |
| 0.8 | 1.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.8 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.8 | 4.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.8 | 2.4 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.8 | 2.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.8 | 9.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.8 | 9.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.8 | 0.8 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
| 0.8 | 2.4 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.8 | 2.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.8 | 2.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.8 | 1.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.8 | 5.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 | 0.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.8 | 13.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.8 | 2.3 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.8 | 2.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.8 | 9.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.8 | 0.8 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 0.8 | 3.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.8 | 3.8 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.7 | 2.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.7 | 3.0 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.7 | 14.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.7 | 2.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.7 | 2.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.7 | 0.7 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.7 | 7.3 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.7 | 7.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.7 | 5.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 | 3.6 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.7 | 1.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.7 | 5.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.7 | 6.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.7 | 1.4 | GO:1990834 | response to odorant(GO:1990834) |
| 0.7 | 3.6 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.7 | 0.7 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.7 | 4.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.7 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.7 | 5.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.7 | 2.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.7 | 5.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.7 | 6.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.7 | 4.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.7 | 1.4 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.7 | 2.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.7 | 6.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.7 | 4.2 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.7 | 2.1 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.7 | 6.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.7 | 2.8 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.7 | 2.8 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.7 | 4.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.7 | 4.9 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.7 | 6.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.7 | 4.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.7 | 5.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.7 | 5.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.7 | 4.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.7 | 4.8 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.7 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.7 | 11.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.7 | 4.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.7 | 1.4 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.7 | 2.0 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.7 | 2.0 | GO:0090285 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.7 | 2.0 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.7 | 0.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.7 | 95.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.7 | 11.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.7 | 8.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.7 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.7 | 0.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.7 | 2.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.7 | 1.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 | 0.7 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.7 | 0.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.7 | 7.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.7 | 2.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.7 | 3.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.7 | 2.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 | 2.0 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.7 | 3.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.7 | 3.9 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.7 | 2.6 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.7 | 3.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.7 | 12.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.6 | 2.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.6 | 7.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.6 | 1.9 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.6 | 3.9 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.6 | 7.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.6 | 9.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.6 | 1.3 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.6 | 5.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.6 | 3.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.6 | 2.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.6 | 7.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.6 | 2.5 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.6 | 6.9 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.6 | 3.1 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.6 | 1.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.6 | 3.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 | 1.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.6 | 19.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.6 | 1.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.6 | 0.6 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 29.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.6 | 4.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.6 | 3.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.6 | 2.4 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
| 0.6 | 4.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.6 | 1.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.6 | 4.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.6 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.6 | 3.0 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
| 0.6 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.6 | 2.4 | GO:0002924 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.6 | 4.2 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.6 | 2.4 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.6 | 6.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.6 | 1.2 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 4.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.6 | 7.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.6 | 3.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.6 | 1.8 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.6 | 10.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.6 | 2.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 1.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.6 | 2.4 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.6 | 4.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.6 | 2.9 | GO:0090625 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.6 | 25.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.6 | 6.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.6 | 4.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.6 | 14.5 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.6 | 6.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.6 | 11.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.6 | 2.3 | GO:0035936 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.6 | 5.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.6 | 4.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.6 | 4.0 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.6 | 1.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.6 | 2.3 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.6 | 0.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.6 | 5.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.6 | 6.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.6 | 7.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.6 | 2.2 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.6 | 3.9 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.6 | 3.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 | 2.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.5 | 2.2 | GO:0090301 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 | 7.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.5 | 5.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.5 | 1.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 0.5 | 1.1 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.5 | 4.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.5 | 4.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.5 | 0.5 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 | 2.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.5 | 9.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.5 | 5.3 | GO:0021794 | thalamus development(GO:0021794) |
| 0.5 | 2.6 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.5 | 1.6 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
| 0.5 | 6.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.5 | 3.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.5 | 6.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.5 | 5.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.5 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.5 | 1.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.5 | 1.5 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.5 | 4.6 | GO:0046959 | habituation(GO:0046959) |
| 0.5 | 3.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.5 | 19.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.5 | 3.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.5 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.5 | 2.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.5 | 2.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 3.1 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.5 | 2.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 | 22.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.5 | 2.0 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.5 | 6.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.5 | 1.5 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.5 | 5.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.5 | 1.0 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.5 | 2.5 | GO:2000870 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
| 0.5 | 2.0 | GO:1903633 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 0.5 | 2.5 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.5 | 4.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.5 | 3.0 | GO:0007129 | synapsis(GO:0007129) |
| 0.5 | 1.5 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.5 | 6.4 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.5 | 2.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.5 | 3.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.5 | 4.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.5 | 2.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.5 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.5 | 2.0 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.5 | 2.9 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
| 0.5 | 5.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.5 | 2.9 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 | 1.9 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.5 | 2.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.5 | 0.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.5 | 2.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
| 0.5 | 1.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 | 1.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 20.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.5 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 | 3.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.5 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 | 3.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.5 | 1.8 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.5 | 1.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.5 | 2.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.5 | 5.9 | GO:0038202 | TORC1 signaling(GO:0038202) |
| 0.5 | 2.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.5 | 1.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.5 | 4.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.4 | 2.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.4 | 2.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 | 1.3 | GO:0032328 | alanine transport(GO:0032328) |
| 0.4 | 7.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.4 | 4.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.4 | 1.3 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.4 | 6.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.4 | 5.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.4 | 1.7 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.4 | 2.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.4 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.4 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.4 | 2.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.4 | 1.3 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.4 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.4 | 1.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 1.3 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.4 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 | 3.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 | 4.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.4 | 1.7 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.4 | 1.3 | GO:0014807 | somatic muscle development(GO:0007525) regulation of somitogenesis(GO:0014807) |
| 0.4 | 3.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.4 | 8.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 | 2.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.4 | 12.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.4 | 3.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.4 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 0.4 | GO:0097272 | ammonia homeostasis(GO:0097272) |
| 0.4 | 1.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.4 | 1.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.4 | 7.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.4 | 1.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.4 | 5.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.4 | 4.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 | 4.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.4 | 1.2 | GO:1990785 | initiation of primordial ovarian follicle growth(GO:0001544) response to water-immersion restraint stress(GO:1990785) |
| 0.4 | 2.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.4 | 1.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.4 | 3.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.4 | 2.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.4 | 4.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.4 | 8.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.4 | 2.7 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.4 | 1.9 | GO:0007494 | midgut development(GO:0007494) |
| 0.4 | 1.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.4 | 8.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.4 | 5.8 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 | 2.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.4 | 8.3 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.4 | 1.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.4 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 | 1.5 | GO:0060073 | micturition(GO:0060073) synaptic transmission involved in micturition(GO:0060084) |
| 0.4 | 9.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.4 | 1.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.4 | 7.4 | GO:0090659 | walking behavior(GO:0090659) |
| 0.4 | 36.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.4 | 5.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.4 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.4 | 6.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.4 | 1.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.4 | 1.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.4 | 1.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.4 | 2.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
| 0.4 | 1.5 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.4 | 2.9 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.4 | 3.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 1.8 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.4 | 3.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.4 | 1.1 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.4 | 1.1 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.4 | 4.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.4 | 14.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.4 | 4.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 1.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.4 | 8.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.4 | 3.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.3 | 2.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 3.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.3 | 4.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.3 | 6.8 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.3 | 2.7 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.3 | 2.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 1.4 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 0.3 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.3 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.3 | 5.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.3 | 26.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.3 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 | 4.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.3 | 2.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.3 | 1.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 | 1.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.3 | 19.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.3 | 1.0 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.3 | 0.3 | GO:0001660 | fever generation(GO:0001660) |
| 0.3 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.3 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
| 0.3 | 2.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 1.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.3 | 5.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 1.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.3 | 1.0 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.3 | 3.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.3 | 20.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.3 | 4.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 1.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.3 | 1.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.3 | 1.8 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
| 0.3 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 2.1 | GO:0072677 | eosinophil migration(GO:0072677) |
| 0.3 | 1.2 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.3 | 3.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 | 3.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.3 | 1.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 | 5.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.3 | 2.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 1.8 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.3 | 2.7 | GO:0006833 | water transport(GO:0006833) |
| 0.3 | 2.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.3 | 0.9 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.3 | 0.6 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.3 | 2.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 | 2.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.3 | 1.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.3 | 16.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.3 | 0.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 1.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 0.6 | GO:0021834 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) dorsal/ventral axon guidance(GO:0033563) |
| 0.3 | 1.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 9.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.3 | 1.1 | GO:0052803 | histamine metabolic process(GO:0001692) imidazole-containing compound metabolic process(GO:0052803) |
| 0.3 | 0.8 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 | 5.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.3 | 0.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.3 | 3.1 | GO:0035878 | nail development(GO:0035878) |
| 0.3 | 4.7 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.3 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.3 | 0.6 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
| 0.3 | 1.4 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.3 | 6.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 3.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 1.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 | 3.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 2.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.3 | 1.1 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.3 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.3 | 0.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 | 1.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.3 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.3 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.3 | 0.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 | 1.1 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.3 | 0.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.3 | 1.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.3 | 2.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.3 | 0.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 1.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 2.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 5.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 1.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 | 1.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 5.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.3 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.3 | 2.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.3 | 2.3 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 0.8 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 1.0 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.3 | 1.0 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 0.5 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 | 1.0 | GO:0071110 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.3 | 1.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.3 | 3.0 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.3 | 1.3 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.2 | 0.5 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 | 0.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.2 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 1.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 | 5.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.2 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 3.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 22.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.2 | 6.4 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.2 | 2.4 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.2 | 1.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 5.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.2 | 6.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.2 | 4.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 3.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 3.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 3.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 2.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.2 | 0.7 | GO:0001759 | organ induction(GO:0001759) |
| 0.2 | 1.8 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.2 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.2 | 0.7 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
| 0.2 | 3.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 2.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 | 4.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 | 0.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 | 6.1 | GO:0007602 | phototransduction(GO:0007602) |
| 0.2 | 1.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 2.7 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.2 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
| 0.2 | 1.0 | GO:0018904 | ether metabolic process(GO:0018904) |
| 0.2 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 1.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.2 | 3.7 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 1.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.2 | 2.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.2 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.2 | 1.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 | 3.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 2.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 0.4 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.2 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.2 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 2.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 6.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.2 | 1.9 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 | 3.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.2 | 3.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.2 | 0.9 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 2.1 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.2 | 0.9 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.2 | 1.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 | 0.5 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
| 0.2 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 1.7 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.2 | 1.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.2 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.2 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 1.3 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 2.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 0.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.2 | 3.8 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.2 | 3.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 2.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.1 | 1.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 2.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.1 | GO:0019724 | B cell mediated immunity(GO:0019724) |
| 0.1 | 2.3 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.1 | 2.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.1 | 0.3 | GO:0072114 | regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.1 | 1.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 0.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 0.4 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
| 0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 1.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 | 3.4 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.5 | GO:0039506 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.1 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 1.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 1.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 2.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 1.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 1.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.1 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.1 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 2.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 3.1 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 0.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 1.5 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 0.6 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 1.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 0.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 5.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.2 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
| 0.1 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 | 13.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.1 | 0.7 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 1.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 0.6 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 1.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 3.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.1 | 0.7 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
| 0.1 | 1.5 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
| 0.1 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 3.6 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.1 | 0.7 | GO:0009582 | detection of abiotic stimulus(GO:0009582) |
| 0.1 | 0.7 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 1.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 1.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 1.3 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.1 | 1.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.1 | GO:0035811 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) negative regulation of urine volume(GO:0035811) |
| 0.1 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 0.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 1.1 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 34.0 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.5 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 1.8 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.2 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 | 0.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.0 | 0.5 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
| 0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.0 | 0.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.0 | 0.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.2 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
| 0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.0 | 1.4 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 | 0.1 | GO:0097500 | protein localization to nonmotile primary cilium(GO:0097499) receptor localization to nonmotile primary cilium(GO:0097500) protein localization to ciliary membrane(GO:1903441) |
| 0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 | 0.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 | 0.3 | GO:0003407 | neural retina development(GO:0003407) |
| 0.0 | 0.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.0 | 0.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.9 | 19.8 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) dimeric IgA immunoglobulin complex(GO:0071750) secretory IgA immunoglobulin complex(GO:0071751) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 7.1 | 21.3 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 4.3 | 17.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 4.2 | 16.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 3.8 | 11.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 3.2 | 15.8 | GO:0036128 | CatSper complex(GO:0036128) |
| 3.1 | 12.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.0 | 56.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 2.9 | 14.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 2.9 | 138.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 2.7 | 13.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 2.7 | 34.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 2.6 | 12.8 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 2.4 | 9.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 2.3 | 6.8 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.2 | 15.6 | GO:1990130 | Iml1 complex(GO:1990130) |
| 2.2 | 6.5 | GO:0032116 | SMC loading complex(GO:0032116) |
| 2.0 | 49.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 2.0 | 2.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 1.9 | 7.6 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 1.9 | 5.6 | GO:0098536 | deuterosome(GO:0098536) |
| 1.9 | 31.6 | GO:0033010 | paranodal junction(GO:0033010) |
| 1.8 | 5.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.8 | 17.7 | GO:0044194 | cytolytic granule(GO:0044194) |
| 1.8 | 24.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 1.7 | 26.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 1.7 | 5.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 1.7 | 11.8 | GO:1990745 | EARP complex(GO:1990745) |
| 1.7 | 6.7 | GO:0071546 | pi-body(GO:0071546) |
| 1.7 | 18.4 | GO:0043203 | axon hillock(GO:0043203) |
| 1.6 | 9.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.6 | 13.2 | GO:0032010 | phagolysosome(GO:0032010) |
| 1.6 | 4.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.6 | 4.9 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 1.6 | 6.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.6 | 4.7 | GO:0098831 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 1.5 | 10.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 1.4 | 10.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.4 | 4.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 1.4 | 7.1 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.4 | 5.5 | GO:0000801 | central element(GO:0000801) |
| 1.4 | 5.5 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 1.4 | 4.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.3 | 14.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 1.3 | 2.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 1.3 | 21.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.3 | 3.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.3 | 10.3 | GO:0072487 | MSL complex(GO:0072487) |
| 1.2 | 3.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 1.2 | 4.9 | GO:0070695 | FHF complex(GO:0070695) |
| 1.2 | 4.8 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 1.2 | 9.6 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.2 | 6.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 1.2 | 12.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 1.2 | 2.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.2 | 4.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.2 | 3.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.2 | 11.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.2 | 3.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 1.2 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 1.1 | 3.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 1.1 | 7.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.1 | 17.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.1 | 5.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.1 | 2.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 1.1 | 29.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 1.1 | 3.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.0 | 3.1 | GO:0070701 | mucus layer(GO:0070701) |
| 1.0 | 19.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 1.0 | 19.7 | GO:0036038 | MKS complex(GO:0036038) |
| 1.0 | 3.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.0 | 5.1 | GO:0044305 | calyx of Held(GO:0044305) |
| 1.0 | 6.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.0 | 7.1 | GO:0043196 | varicosity(GO:0043196) |
| 1.0 | 15.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 1.0 | 159.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 1.0 | 17.6 | GO:0000786 | nucleosome(GO:0000786) |
| 0.9 | 8.4 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.9 | 2.8 | GO:0060987 | lipid tube(GO:0060987) |
| 0.9 | 16.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.9 | 22.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.9 | 15.8 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.9 | 5.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.9 | 5.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.9 | 14.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.8 | 4.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.8 | 14.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.8 | 12.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.8 | 4.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.8 | 17.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.8 | 4.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.8 | 4.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.8 | 2.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.8 | 3.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 21.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.8 | 27.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.8 | 5.3 | GO:0098533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) |
| 0.7 | 3.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.7 | 3.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.7 | 6.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.7 | 3.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.7 | 8.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.7 | 1.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.7 | 8.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.7 | 6.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.7 | 2.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.7 | 3.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.7 | 6.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.7 | 7.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 2.6 | GO:1990879 | CST complex(GO:1990879) |
| 0.6 | 3.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.6 | 6.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.6 | 5.5 | GO:0097433 | dense body(GO:0097433) |
| 0.6 | 7.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.6 | 4.9 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.6 | 3.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.6 | 3.0 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.6 | 2.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.6 | 14.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.6 | 2.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.6 | 2.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.6 | 3.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.6 | 1.7 | GO:0044447 | axoneme part(GO:0044447) |
| 0.5 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.5 | 5.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.5 | 1.6 | GO:0043293 | apoptosome(GO:0043293) |
| 0.5 | 3.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.5 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.5 | 8.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.5 | 25.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.5 | 1.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.5 | 1.6 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.5 | 9.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.5 | 2.6 | GO:0001652 | granular component(GO:0001652) |
| 0.5 | 6.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.5 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 2.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 2.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.5 | 44.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.5 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 9.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.5 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.5 | 5.5 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
| 0.5 | 4.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.5 | 1.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.5 | 4.3 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.5 | 8.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.5 | 4.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.5 | 50.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.5 | 3.6 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.5 | 4.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.4 | 4.0 | GO:0071437 | invadopodium(GO:0071437) |
| 0.4 | 8.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.4 | 16.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.4 | 1.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.4 | 8.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.4 | 7.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.4 | 19.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.4 | 7.5 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 5.4 | GO:0005921 | gap junction(GO:0005921) |
| 0.4 | 3.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.4 | 4.9 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.4 | 1.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.4 | 2.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.4 | 1.2 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.4 | 5.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.4 | 6.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.4 | 3.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 0.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.4 | 3.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.4 | 44.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.4 | 1.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.4 | 16.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.4 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.4 | 4.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.4 | 9.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.4 | 1.4 | GO:0035363 | histone locus body(GO:0035363) |
| 0.4 | 5.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.4 | 3.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 7.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.3 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 4.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.3 | 20.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 10.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 3.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.3 | 19.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 21.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.3 | 1.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.3 | 4.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.3 | 0.9 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.3 | 10.1 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.3 | 1.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.3 | 16.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.3 | 5.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 1.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 1.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 9.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.3 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.3 | 5.2 | GO:0042627 | chylomicron(GO:0042627) |
| 0.3 | 65.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 4.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.3 | 1.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 5.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.2 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 2.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 1.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 4.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 16.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 13.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.2 | 20.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.2 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 9.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 2.6 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 4.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 1.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 4.1 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 1.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.2 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 5.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.2 | 5.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.2 | 2.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.2 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 16.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 1.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 3.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 0.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 4.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 0.5 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.2 | 22.4 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 7.4 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.2 | 1.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 21.7 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.2 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.2 | 0.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 4.7 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 1.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 1.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 27.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 4.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 5.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 1.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 159.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 1.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 16.9 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 2.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 1.3 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.4 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 1.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.1 | 9.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 10.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.1 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 5.7 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 3.6 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 181.6 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 1.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.4 | 49.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 7.5 | 22.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 4.2 | 16.8 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 3.6 | 18.0 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 3.5 | 17.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 3.4 | 13.8 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 3.4 | 13.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 3.1 | 9.4 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 3.1 | 12.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 3.0 | 9.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 3.0 | 8.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 2.9 | 11.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 2.9 | 173.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 2.8 | 8.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 2.8 | 38.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 2.6 | 15.8 | GO:0003796 | lysozyme activity(GO:0003796) |
| 2.5 | 7.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 2.5 | 10.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 2.5 | 10.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 2.5 | 7.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 2.4 | 22.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 2.3 | 9.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 2.3 | 6.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 2.3 | 6.8 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 2.3 | 9.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 2.2 | 17.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 2.2 | 8.7 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 2.2 | 10.8 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
| 2.1 | 8.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.1 | 10.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 2.1 | 19.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 2.1 | 8.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.1 | 10.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.1 | 6.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 2.0 | 17.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 2.0 | 17.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 2.0 | 11.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 2.0 | 4.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 2.0 | 5.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 1.9 | 7.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 1.9 | 7.5 | GO:0035473 | lipase binding(GO:0035473) |
| 1.8 | 5.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 1.8 | 26.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 1.8 | 10.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 1.8 | 21.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 1.8 | 21.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.7 | 5.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.7 | 6.9 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 1.7 | 6.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.7 | 10.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 1.7 | 6.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 1.7 | 5.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.7 | 8.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 1.7 | 285.0 | GO:0003823 | antigen binding(GO:0003823) |
| 1.6 | 6.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 1.6 | 24.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 1.6 | 9.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.6 | 1.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 1.6 | 4.8 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 1.6 | 16.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.6 | 1.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 1.6 | 22.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 1.6 | 7.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.6 | 4.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.5 | 6.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.5 | 9.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 1.5 | 4.6 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 1.5 | 9.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.5 | 10.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 1.5 | 4.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 1.5 | 4.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 1.5 | 5.8 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 1.4 | 5.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.4 | 4.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.4 | 4.3 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 1.4 | 18.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 1.4 | 4.2 | GO:0042806 | fucose binding(GO:0042806) |
| 1.4 | 6.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 1.4 | 4.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 1.4 | 1.4 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 1.3 | 6.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 1.3 | 6.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 1.3 | 5.3 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 1.3 | 3.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.3 | 5.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 1.3 | 11.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 1.3 | 3.8 | GO:0035375 | zymogen binding(GO:0035375) |
| 1.3 | 7.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 1.3 | 3.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 1.3 | 17.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.2 | 7.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 1.2 | 7.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.2 | 6.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.2 | 3.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 1.2 | 6.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.2 | 9.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.2 | 4.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 1.2 | 4.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.2 | 4.8 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.2 | 1.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.2 | 1.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.2 | 13.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.2 | 12.0 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 1.2 | 4.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 1.2 | 10.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 1.2 | 5.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.2 | 3.5 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 1.2 | 4.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.2 | 5.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.2 | 5.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.2 | 11.6 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 1.2 | 5.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 1.2 | 12.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 1.2 | 12.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 1.1 | 10.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 1.1 | 2.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 1.1 | 6.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 1.1 | 3.3 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.1 | 8.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.1 | 5.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 1.1 | 3.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.1 | 3.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 1.1 | 3.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.1 | 4.4 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.1 | 10.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.1 | 5.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 1.1 | 4.4 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 1.1 | 4.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 1.1 | 9.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 1.1 | 5.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.1 | 3.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 1.1 | 4.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 1.1 | 5.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 1.1 | 8.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 1.1 | 5.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.0 | 3.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 1.0 | 3.1 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 1.0 | 8.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 1.0 | 5.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 1.0 | 5.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 1.0 | 6.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 1.0 | 5.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.0 | 6.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 1.0 | 26.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 1.0 | 18.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 1.0 | 6.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 1.0 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 1.0 | 4.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 1.0 | 8.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.0 | 3.0 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.0 | 5.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 1.0 | 2.9 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 1.0 | 2.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.9 | 25.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.9 | 12.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.9 | 5.7 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.9 | 12.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.9 | 12.2 | GO:0019864 | IgG binding(GO:0019864) |
| 0.9 | 1.9 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.9 | 10.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.9 | 4.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.9 | 8.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.9 | 13.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.9 | 6.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.9 | 2.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.9 | 8.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.9 | 5.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.9 | 7.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.9 | 4.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.9 | 9.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.9 | 6.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.9 | 15.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.9 | 2.7 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.9 | 28.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.9 | 2.7 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.9 | 18.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.9 | 1.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.9 | 7.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.9 | 6.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.9 | 2.6 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.9 | 15.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.8 | 3.4 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.8 | 5.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.8 | 5.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.8 | 2.5 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
| 0.8 | 11.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.8 | 4.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.8 | 13.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.8 | 13.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.8 | 6.5 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.8 | 44.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.8 | 8.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.8 | 5.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.8 | 4.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.8 | 2.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.8 | 4.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.8 | 7.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.8 | 4.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.8 | 3.1 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.8 | 3.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.8 | 2.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.8 | 3.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.8 | 2.3 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.8 | 2.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.8 | 7.0 | GO:0043426 | MRF binding(GO:0043426) |
| 0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.8 | 4.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.8 | 9.1 | GO:0008430 | selenium binding(GO:0008430) |
| 0.8 | 2.3 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.8 | 3.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.7 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.7 | 3.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.7 | 3.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.7 | 2.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.7 | 22.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.7 | 5.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.7 | 26.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.7 | 5.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.7 | 4.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.7 | 11.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.7 | 2.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.7 | 7.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.7 | 2.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.7 | 5.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.7 | 6.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.7 | 2.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.7 | 1.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.7 | 2.1 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.7 | 8.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.7 | 2.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.7 | 4.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.7 | 0.7 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.7 | 7.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.7 | 16.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.7 | 2.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.7 | 4.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.7 | 5.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.7 | 6.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.7 | 10.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.7 | 18.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.7 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.7 | 9.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.7 | 2.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.7 | 5.4 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.7 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.7 | 2.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.7 | 3.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.7 | 2.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.7 | 6.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.7 | 2.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.7 | 7.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.7 | 2.0 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.7 | 2.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.7 | 11.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.7 | 3.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.7 | 1.3 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.6 | 1.9 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.6 | 7.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.6 | 1.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.6 | 13.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.6 | 6.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.6 | 1.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.6 | 3.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 3.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.6 | 3.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.6 | 3.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.6 | 5.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.6 | 6.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.6 | 4.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.6 | 12.9 | GO:0001083 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
| 0.6 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 1.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.6 | 1.8 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.6 | 7.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.6 | 3.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.6 | 5.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.6 | 1.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.6 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.6 | 3.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.6 | 4.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.6 | 2.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.6 | 3.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.6 | 18.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.6 | 0.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.6 | 7.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.6 | 2.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.6 | 3.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.6 | 7.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.6 | 2.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.6 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.6 | 4.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.6 | 4.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.6 | 2.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.6 | 2.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.6 | 5.1 | GO:0015250 | water channel activity(GO:0015250) |
| 0.6 | 2.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.6 | 3.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 2.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.6 | 7.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.6 | 2.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.6 | 2.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.6 | 2.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.5 | 4.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.5 | 29.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.5 | 2.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.5 | 16.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.5 | 1.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.5 | 2.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.5 | 2.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.5 | 17.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.5 | 2.7 | GO:0047374 | sterol esterase activity(GO:0004771) methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.5 | 3.7 | GO:0019863 | IgE binding(GO:0019863) |
| 0.5 | 0.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.5 | 3.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.5 | 1.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.5 | 6.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.5 | 1.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.5 | 6.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.5 | 2.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 2.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.5 | 3.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.5 | 23.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.5 | 2.6 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.5 | 11.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.5 | 9.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.5 | 7.6 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.5 | 9.6 | GO:0005522 | profilin binding(GO:0005522) |
| 0.5 | 2.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.5 | 2.0 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.5 | 16.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.5 | 5.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.5 | 2.9 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.5 | 1.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.5 | 5.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.5 | 2.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.5 | 1.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.5 | 4.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.5 | 1.9 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.5 | 21.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.5 | 48.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.5 | 6.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.5 | 4.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 6.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.5 | 3.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.5 | 1.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.5 | 3.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.5 | 0.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.5 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.4 | 4.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.4 | 9.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.4 | 0.9 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.4 | 2.7 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.4 | 1.3 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.4 | 1.8 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.4 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.4 | 2.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.4 | 2.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.4 | 2.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.4 | 3.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.4 | 3.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 6.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 2.6 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.4 | 3.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
| 0.4 | 8.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.4 | 2.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.4 | 3.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.4 | 8.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.4 | 9.1 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.4 | 4.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.4 | 2.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.4 | 8.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.4 | 4.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.4 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 6.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.4 | 2.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.4 | 6.8 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 2.0 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.4 | 5.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.4 | 2.0 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.4 | 4.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.4 | 0.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.4 | 7.4 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.4 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.4 | 0.8 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.4 | 5.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.4 | 5.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.4 | 2.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.4 | 2.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 8.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.4 | 10.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.4 | 4.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.4 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 36.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.4 | 5.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 2.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.4 | 11.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.4 | 23.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.4 | 2.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.4 | 1.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.4 | 8.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 2.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.3 | 1.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 4.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 2.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.3 | 4.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 40.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.3 | 3.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 50.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.3 | 3.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 3.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 4.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 3.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.3 | 4.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.3 | 2.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.3 | 37.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 1.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 6.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.3 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 10.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.3 | 12.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.3 | 0.3 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.3 | 2.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 1.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.3 | 1.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.3 | 1.0 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.3 | 0.9 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.3 | 4.1 | GO:0009374 | biotin binding(GO:0009374) |
| 0.3 | 4.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.3 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 7.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.3 | 15.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.3 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 67.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.3 | 3.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 3.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.3 | 2.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.3 | 2.1 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.3 | 5.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 0.9 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 1.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.3 | 3.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.3 | 22.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.3 | 0.9 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.3 | 2.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.3 | 1.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 2.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 1.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.3 | 3.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.3 | 8.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.3 | 2.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.3 | 0.8 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
| 0.3 | 6.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.3 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 8.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.3 | 1.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.3 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.3 | 9.2 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.3 | 4.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.3 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
| 0.3 | 1.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.3 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.3 | 1.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.3 | 1.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.3 | 1.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.3 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 4.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 5.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.2 | 1.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.2 | 1.4 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.2 | 0.5 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 1.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.2 | 3.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 6.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.2 | 1.1 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.2 | 6.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 3.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 1.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.2 | 4.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.2 | 15.3 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.2 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.2 | 2.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 48.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.2 | 0.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 20.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.2 | 0.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.2 | 2.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.2 | 5.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 15.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.2 | 5.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 1.3 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 2.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 1.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 1.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.2 | 2.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 50.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 0.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.2 | 0.7 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.2 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 0.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 1.6 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 15.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.2 | 0.8 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.2 | 0.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.2 | 0.7 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 2.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 8.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.2 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.2 | 4.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.2 | 0.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 1.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 3.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 0.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.2 | 0.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.6 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.1 | 0.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.9 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 3.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 1.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 5.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 1.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 3.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 4.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.1 | 2.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 2.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 0.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 1.4 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 1.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.5 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 0.1 | 0.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.3 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.1 | 0.3 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.1 | 1.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 2.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.1 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 1.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 6.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.1 | 1.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 103.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 7.9 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.3 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 1.0 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 2.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 2.9 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 4.1 | GO:0005261 | cation channel activity(GO:0005261) |
| 0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 6.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.4 | GO:0070699 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
| 0.1 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 0.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.2 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.1 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 3.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 7.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.0 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.0 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.1 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.0 | 0.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 5.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 2.1 | 4.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 1.5 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 1.5 | 2.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 1.4 | 10.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 1.1 | 54.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 1.0 | 3.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.9 | 2.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.9 | 30.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 3.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.8 | 12.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.8 | 22.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.8 | 9.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.7 | 4.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.7 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.7 | 22.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.7 | 10.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.6 | 11.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.6 | 7.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.6 | 34.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.6 | 2.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.6 | 10.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.6 | 2.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.6 | 24.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.5 | 5.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.5 | 3.6 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.5 | 2.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.5 | 6.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.5 | 29.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.5 | 25.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.4 | 2.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.4 | 2.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.4 | 2.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.4 | 4.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.4 | 8.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.4 | 14.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 4.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.4 | 2.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.4 | 4.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 7.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.4 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 5.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.4 | 6.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.4 | 26.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.4 | 19.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.4 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.4 | 4.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.4 | 27.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 6.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.3 | 3.0 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 7.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 13.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.3 | 5.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 7.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.3 | 100.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.3 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 10.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.3 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.3 | 3.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.3 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 6.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 10.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 3.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.2 | 3.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 5.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 2.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.2 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 4.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.2 | 15.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.2 | 38.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 5.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 8.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 3.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 3.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.2 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 6.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 6.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 4.6 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 20.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.2 | 4.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 5.8 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 8.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 1.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 4.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 5.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 21.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 2.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 2.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 1.8 | 19.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 1.6 | 6.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 1.5 | 35.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.4 | 2.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 1.4 | 28.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.3 | 23.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.3 | 40.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 1.3 | 21.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 1.2 | 2.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 1.2 | 24.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.1 | 14.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 1.1 | 1.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 1.0 | 11.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.0 | 6.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.0 | 63.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 1.0 | 12.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.9 | 79.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.9 | 25.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.9 | 20.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.9 | 40.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.9 | 26.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.9 | 11.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.8 | 20.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.8 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.8 | 28.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.8 | 10.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.7 | 8.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.7 | 10.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.7 | 26.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.7 | 14.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.7 | 14.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.7 | 2.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.7 | 3.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.6 | 3.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
| 0.6 | 12.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.6 | 4.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.5 | 28.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.5 | 5.7 | REACTOME OPSINS | Genes involved in Opsins |
| 0.5 | 3.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.5 | 12.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.5 | 29.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.5 | 14.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.5 | 9.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.5 | 20.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.5 | 4.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.5 | 9.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.5 | 1.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.5 | 9.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.5 | 3.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.5 | 70.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.5 | 33.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.4 | 6.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.4 | 11.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 3.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.4 | 3.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.4 | 55.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.4 | 9.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.4 | 6.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.4 | 2.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.4 | 7.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 10.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.4 | 15.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 3.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.4 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.4 | 31.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.4 | 14.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 4.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.4 | 4.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.4 | 47.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.4 | 6.2 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.4 | 6.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 6.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 14.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 13.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 8.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 4.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.3 | 6.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 5.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.3 | 5.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.3 | 2.5 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.3 | 6.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 13.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.3 | 2.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 1.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 7.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.3 | 2.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.3 | 10.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 4.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.3 | 3.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 8.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.3 | 1.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 2.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.2 | 8.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 23.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 21.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 97.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.2 | 1.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 2.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.2 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 3.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 3.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 5.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.2 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 6.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.2 | 11.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 2.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 1.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.2 | 3.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 2.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 5.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 3.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 6.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 2.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 3.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 1.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 1.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |